Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, spain, and the Netherlands

American Journal of Gastroenterology

Volumn 109, Issue 3, 2014, Pages 336-343

  Kroep, S ^a   Lansdorp Vogelaar, I ^a   Rubenstein, J H ^b   Lemmens, V E P P ^a,c   Van Heijningen, E B ^a   Aragones N ^d,e   Van Ballegooijen, M ^a   Inadomi, J M ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Eindhoven Cancer Registry   (Netherlands)

^d CARLOS III INSTITUTE OF HEALTH   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NETHERLANDS; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; SPAIN; UNITED STATES;

ADENOCARCINOMA; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; INCIDENCE; LIFE STYLE; NETHERLANDS; REGISTRIES; RISK FACTORS; SPAIN; UNITED STATES;

EID: 84895790689     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.420     Document Type: Article

References (46)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Botterweck AA, Schouten LJ, Volovics A et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-54.
3. Aragones N, Izarzugaza MI, Ramos mos M et al. Trends in oesophago-gastric cancer incidence in Spain: analysis by subsite and histology. Ann Oncol 2010; 21 (Suppl 3): iii69-75.
4. Lepage C, Rachet B, Jooste V et al. Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol 2008; 103: 2694-9.
5. Vizcaino AP, Moreno V, Lambert R et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002; 99: 860-8.
6. Dikken JL, Lemmens VE, Wouters MW et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 2012; 48: 1624-32.
7. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev 2010; 19: 1468-70.
8. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008; 100: 1184-7.
9. Parfitt JR, Miladinovic Z, Driman DK. Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada-an epidemiological study from 1964-2002. Can J Gastroenterol 2006; 20: 271-6.
10. Bosetti C, Levi F, Ferlay J et al. Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 2008; 122: 1118-29.
11. Schmassmann A, Oldendorf MG, Gebbers JO. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 2009; 24: 603-9.
12. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 2008; 123: 1422-8.
13. Steevens J, Botterweck AA, Dirx MJ et al. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2010; 22: 669-78.
14. Bhat S, Coleman HG, Yousef F et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103: 1049-57.
15. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8.
16. Yousef F, Cardwell C, Cantwell MM et al. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008; 168: 237-49.
17. Lagergren J, Bergstrom R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
18. Kamangar F, Chow WH, Abnet CC et al. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009; 38: 27-57, vii.
19. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872-8.
20. Cook MB, Kamangar F, Whiteman DC et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst 2010; 102: 1344-53.
21. Freedman ND, Murray LJ, Kamangar F et al. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut 2011; 60: 1029-37.
22. Tramacere I, Pelucchi C, Bagnardi V et al. A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. Ann Oncol 2012; 23: 287-97.
23. Bolton-Smith C, Woodward M, Tunstall-Pedoe H et al. Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health 2000; 54: 143-8.
24. Yun S, Zhu BP, Black W et al. A comparison of national estimates of obesity prevalence from the behavioral risk factor surveillance system and the National Health and Nutrition Examination Survey. Int J Obes (Lond) 2006; 30: 164-70.
25. Basterra-Gortari FJ, Bes-Rastrollo M, Forga ga L et al. [Validity of self-reported body mass index in the National Health Survey] Validacion del indice de masa corporal auto-referido en la Encuesta Nacional de Salud. An Sist Sanit Navar 2007; 30: 373-81.
26. Visscher TL, Viet AL, Kroesbergen IH et al. Underreporting of BMI in adults and its Effect on obesity prevalence estimations in the period 1998 to 2001. Obesity (Silver Spring) 2006; 14: 2054-63.
27. Nyholm M, Gullberg B, Merlo J et al. The validity of obesity based on selfreported weight and height: implications for population studies. Obesity (Silver Spring) 2007; 15: 197-208.
28. Ezzati M, Martin H, Skjold S et al. Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med 2006; 99: 250-7.
29. Centers for Disease Control and revention/NationalCenter for Health Statistics/U. S. Department of Health and human Services, National Health Interview Survey (NHIS).
30. Desai TK, Krishnan K, Samala N et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2012; 61: 970-6.
31. Statistics Netherlands. http://www.cbs.nl/en-GB/menu/home/default.htm
32. OECD OECD Health Data: non-medical determinants of health.
33. Centers for Disease control and Prevention/National Center for Health Statistics/U.S. Department of Health and Human Services, National Health and Nutrition Examination Survey (NHANES).
34. Regidor E, Gutierrez-Fisac JL, de los Santos Ichaso M et al. Trends in principal cancer risk factors in Spain. Ann Oncol 2010; 21 (Suppl 3): iii37-42.
35. Fernández E, Schiaffino A, García M et al. Smoking in Spain, 1945-1995. A retrospective analysis based on the Spanish National Health Interview Surveys. Med Clin (Barc) 2003; 120: 14-6.
36. STIVORO. Dutch expert centre for tobacco control. http://www.stivoro. nl/Upload/Trendpublicatie%20Percentage%20Rokers%202010.pdf.
37. World Health Organization. Global Health Observatory (GHO). http://www.who.int/gho/database/en/.
38. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM (ed). Cancer Registration Principles and Methods. IARC: Lyon, 1991, pp 126-58.
39. Kim HJ, Fay MP, Feuer EJ. et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51.
40. Clegg LX, Gail MH, Feuer EJ. Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics 2002; 58: 684-8.
41. Wilsnack RW, Wilsnack SC, Kristjanson AF et al. Gender and alcohol consumption: patterns from the multinational GENACIS project. Addiction 2009; 104: 1487-500.
42. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008; 1: 329-38.
43. Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila) 2008; 1: 308-11.
44. Sonnenberg A. Effects of environment and lifestyle on gastroesophageal reflux disease. Dig Dis 2011; 29: 229-34.
45. Edgren G, Adami HO, Weiderpass Vainio E et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013; 62: 1406-14.
46. Bollschweiler E, Wolfgarten E, Gutschow C et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549-55.